<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">32105043</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>31</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">0807-7096</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>140</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke</Title>
          <ISOAbbreviation>Tidsskr Nor Laegeforen</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Cosmetic breast implants and breast cancer].</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4045/tidsskr.19.0266</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">The number of women with cosmetic breast implants has increased in recent decades in Norway. We compared the risk of detecting breast cancer and histopathological characteristics of the tumours in women with and without implants.</AbstractText>
          <AbstractText Label="MATERIAL AND METHOD">We retrieved information from the Cancer Registry's databases on implants and breast cancer among women who had participated in BreastScreen Norway in the period 1996-2016. Use of the data is pursuant to the Cancer Registry Regulations. We identified 785 706 women, of whom 10 086 (1.3 %) reported that they had an implant. We calculated the incidence rate ratio (IRR) with a 95 % confidence interval (95 % CI) for detected breast cancer and compared histopathological tumour characteristics among women with and without implants with the aid of descriptive analyses.</AbstractText>
          <AbstractText Label="RESULTS">The incidence rate ratio for breast cancer was 30 % lower for women with implants than for women without (IRR 0.70 (95 % CI 0.60-0.81)). Women with implants who had cancer detected had tumours with a larger diameter than women without, and several of these women had metastasis to axillary lymph nodes.</AbstractText>
          <AbstractText Label="INTERPRETATION">Women with implants who participated in BreastScreen Norway had a lower risk of detection of breast cancer, but more advanced disease upon diagnosis than those without implants. This may be due to the difficulty caused by implants in performing and interpreting the mammograms. The women should be informed about this before undergoing augmentation mammoplasty.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sondén</LastName>
            <ForeName>Emma Caroline Bekkelund</ForeName>
            <Initials>ECB</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sebuødegård</LastName>
            <ForeName>Sofie</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Korvald</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lømo</LastName>
            <ForeName>Jon</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schlichting</LastName>
            <ForeName>Ellen</ForeName>
            <Initials>E</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brandal</LastName>
            <ForeName>Siri Helene Bertelsen</ForeName>
            <Initials>SHB</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hofvind</LastName>
            <ForeName>Solveig</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>nor</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Kosmetiske brystimplantater og brystkreft.</VernacularTitle>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Norway</Country>
        <MedlineTA>Tidsskr Nor Laegeforen</MedlineTA>
        <NlmUniqueID>0413423</NlmUniqueID>
        <ISSNLinking>0029-2001</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Tidsskr Nor Laegeforen. 2020 May 25;140(8):</RefSource>
          <PMID Version="1">32463197</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Tidsskr Nor Laegeforen. 2020 May 25;140(8):</RefSource>
          <PMID Version="1">32463198</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D018427" MajorTopicYN="Y">Breast Implants</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008327" MajorTopicYN="N">Mammography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32105043</ArticleId>
        <ArticleId IdType="doi">10.4045/tidsskr.19.0266</ArticleId>
        <ArticleId IdType="pii">19-0266</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
